Aarti Drugs Limited
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations.
What Aarti files
- Others64
- Investor Meet39
- Updates15
- Important12
- Board Meeting10
- PPTs6
Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication
Aarti Drugs filed its FY26 Sustainability Report. The company temporarily stopped a chlorosulfonation process at its T-150 unit following an HCl gas leak, per MPCB directives. It reported a Turnover of ₹2,260.39 Cr, boosting R&D/Capex for environmental and social improvements, including ZLD at 10 API facilities.
Aarti Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026
Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication
Aarti Drugs' board approved a new Performance Stock Option Plan 2026 to grant up to 0.08 Cr options to eligible employees, pending shareholder approval. This strategic move aims to incentivize its workforce.